Progyny, Inc.
PGNY
$22.30
$0.351.60%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 324.04M | 298.43M | 286.63M | 304.09M | 278.08M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 324.04M | 298.43M | 286.63M | 304.09M | 278.08M |
| Cost of Revenue | 248.24M | 235.00M | 227.38M | 235.81M | 215.67M |
| Gross Profit | 75.80M | 63.43M | 59.24M | 68.28M | 62.41M |
| SG&A Expenses | 51.63M | 47.65M | 46.79M | 47.59M | 43.88M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 299.87M | 282.64M | 274.17M | 283.40M | 259.56M |
| Operating Income | 24.17M | 15.79M | 12.46M | 20.69M | 18.52M |
| Income Before Tax | 26.54M | 17.66M | 17.96M | 25.07M | 22.52M |
| Income Tax Expenses | 11.48M | 7.13M | 7.54M | 8.58M | 5.62M |
| Earnings from Continuing Operations | 15.06M | 10.53M | 10.42M | 16.49M | 16.90M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 15.06M | 10.53M | 10.42M | 16.49M | 16.90M |
| EBIT | 24.17M | 15.79M | 12.46M | 20.69M | 18.52M |
| EBITDA | 25.28M | 16.66M | 13.30M | 21.44M | 19.24M |
| EPS Basic | 0.18 | 0.12 | 0.12 | 0.18 | 0.18 |
| Normalized Basic EPS | 0.19 | 0.13 | 0.12 | 0.14 | 0.12 |
| EPS Diluted | 0.17 | 0.12 | 0.11 | 0.17 | 0.17 |
| Normalized Diluted EPS | 0.19 | 0.12 | 0.12 | 0.14 | 0.12 |
| Average Basic Shares Outstanding | 85.50M | 85.81M | 90.07M | 93.87M | 96.48M |
| Average Diluted Shares Outstanding | 89.31M | 88.91M | 93.82M | 97.84M | 101.05M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |